Eligible residents living with diabetes in Saskatchewan who rely on any type of insulin may be eligible to receive coverage ...
Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
5d
Zacks.com on MSNDXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 ApprovalDexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The ...
The agency also flagged issues related to how the company addressed a deficiency in G6 sensors ... during the first quarter. Dexcom has submitted its 15-day G7 CGM for FDA review and is still ...
A new clinical trial led by the Jaeb Center for Health Research has shown that automated insulin delivery (AID) systems can significantly improve blood sugar control in adults with type 2 diabetes who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results